AEHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aehr Test Systems (AEHR) is not a strong buy for a beginner investor with a long-term strategy at this moment. While there are positive catalysts such as recent orders and analyst upgrades, the stock's recent price decline, insider selling, and weak financial performance suggest caution. Holding the stock or waiting for a better entry point may be more prudent.
The technical indicators are mixed. The MACD is positive but contracting, RSI is neutral at 57.66, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading closer to its support level (S1: 32.274) than its resistance level (R1: 45.285), indicating potential downside risk.
Recent $14 million order for AI chip manufacturing and testing equipment.
Follow-on purchase order for silicon photonics testing systems.
Analyst upgrade by William Blair with a fair value estimate of $50-$70 per share.
Insiders are selling, with a 252.27% increase in selling activity over the last month.
Revenue dropped significantly (-26.53% YoY) in the latest quarter.
Lower-than-expected guidance for fiscal 2026 ($25M-$30M vs. prior $42M).
In Q2 2026, revenue dropped by 26.53% YoY to $9.88M, and gross margin declined by 35.85% to 25.75%. However, net income improved by 214.20% YoY to -$3.23M, and EPS increased by 266.67% to -0.11.
Analyst sentiment is mixed. William Blair upgraded the stock to Outperform with a fair value of $50-$70, citing strong design wins and a growing market for burn-in tools. However, Craig-Hallum lowered the price target to $21 due to weak guidance and results. Lake Street initiated coverage with a Buy rating and a $29 price target, highlighting the company's unique positioning in the semiconductor testing market.
